Your browser doesn't support javascript.
loading
Immune recognition of syngeneic, allogeneic and xenogeneic stromal cell transplants in healthy retinas.
Norte-Muñoz, María; Gallego-Ortega, Alejandro; Lucas-Ruiz, Fernando; González-Riquelme, María J; Changa-Espinoza, Yazmín I; Galindo-Romero, Caridad; Ponsaerts, Peter; Vidal-Sanz, Manuel; García-Bernal, David; Agudo-Barriuso, Marta.
  • Norte-Muñoz M; Experimental Ophthalmology Group, Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Arrixaca) & Universidad de Murcia, Murcia, Spain.
  • Gallego-Ortega A; Experimental Ophthalmology Group, Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Arrixaca) & Universidad de Murcia, Murcia, Spain.
  • Lucas-Ruiz F; Experimental Ophthalmology Group, Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Arrixaca) & Universidad de Murcia, Murcia, Spain.
  • González-Riquelme MJ; Experimental Ophthalmology Group, Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Arrixaca) & Universidad de Murcia, Murcia, Spain.
  • Changa-Espinoza YI; Experimental Ophthalmology Group, Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Arrixaca) & Universidad de Murcia, Murcia, Spain.
  • Galindo-Romero C; Experimental Ophthalmology Group, Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Arrixaca) & Universidad de Murcia, Murcia, Spain.
  • Ponsaerts P; Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, Antwerp, Belgium.
  • Vidal-Sanz M; Experimental Ophthalmology Group, Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Arrixaca) & Universidad de Murcia, Murcia, Spain.
  • García-Bernal D; Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Arrixaca) & Biochemistry, Molecular Biology and Immunology Department, Universidad de Murcia, Murcia, Spain. david.garcia23@um.es.
  • Agudo-Barriuso M; Experimental Ophthalmology Group, Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Arrixaca) & Universidad de Murcia, Murcia, Spain. martabar@um.es.
Stem Cell Res Ther ; 13(1): 430, 2022 08 20.
Article en En | MEDLINE | ID: mdl-35987845
ABSTRACT

BACKGROUND:

Advanced therapies using adult mesenchymal stromal cells (MSCs) for neurodegenerative diseases are not effectively translated into the clinic. The cross talk between the transplanted cells and the host tissue is something that, despite its importance, is not being systematically investigated.

METHODS:

We have compared the response of the mouse healthy retina to the intravitreal transplantation of MSCs derived from the bone marrow in four modalities syngeneic, allogeneic, xenogeneic and allogeneic with immunosuppression using functional analysis in vivo and histology, cytometry and protein measurement post-mortem. Data were considered significant (p < 0.05) after nonparametric suitable statistical tests.

RESULTS:

Transplanted cells remain in the vitreous and are cleared by microglial cells a process that is quicker in allotransplants regardless of immunosuppression. All transplants cause anatomical remodelling which is more severe after xenotransplants. Xeno- and allotransplants with or without immunosuppression cause macro- and microglial activation and retinal functional impairment, being xenotransplants the most detrimental and the only ones that recruit CD45+Iba1-cells. The profile of proinflammatory cytokines changes in all transplantation settings. However, none of these changes affect the retinal ganglion cell population.

CONCLUSIONS:

We show here a specific functional and anatomical retinal response depending on the MSC transplantation modality, an aspect that should be taken into consideration when conducting preclinical studies if we intend a more realistic translation into clinical practice.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Trasplante de Células Madre Mesenquimatosas / Células Madre Mesenquimatosas Límite: Animals Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Trasplante de Células Madre Mesenquimatosas / Células Madre Mesenquimatosas Límite: Animals Idioma: En Año: 2022 Tipo del documento: Article